View of RESEARCH ON THE CLINICAL AND PARACLINICAL CHARACTERISTICS AND RESULTS OF DAPAGLIFLOZIN COMBINATION REGIMEN TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE MILDLY-REDUCED EJECTION FRACTION AT KIEN GIANG GENERAL HOSPITAL IN 2023

Return to Article Details RESEARCH ON THE CLINICAL AND PARACLINICAL CHARACTERISTICS AND RESULTS OF DAPAGLIFLOZIN COMBINATION REGIMEN TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE MILDLY-REDUCED EJECTION FRACTION AT KIEN GIANG GENERAL HOSPITAL IN 2023–2024 Download Download PDF